Notice: This company has been marked as potentially delisted and may not be actively trading. LogicBio Therapeutics (LOGC) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsEarningsInsider TradesOptions ChainOwnershipShort InterestSustainabilityTrends LOGC vs. DDL, SFIX, HNST, BWMX, TDUP, BZUN, AKA, DIBS, QRTEA, and LVLUShould you be buying LogicBio Therapeutics stock or one of its competitors? The main competitors of LogicBio Therapeutics include Dingdong (Cayman) (DDL), Stitch Fix (SFIX), Honest (HNST), Betterware de México, S.A.P.I. de C.V. (BWMX), ThredUp (TDUP), Baozun (BZUN), a.k.a. Brands (AKA), 1stdibs.Com (DIBS), Qurate Retail (QRTEA), and Lulu's Fashion Lounge (LVLU). These companies are all part of the "catalog & mail-order houses" industry. LogicBio Therapeutics vs. Dingdong (Cayman) Stitch Fix Honest Betterware de México, S.A.P.I. de C.V. ThredUp Baozun a.k.a. Brands 1stdibs.Com Qurate Retail Lulu's Fashion Lounge LogicBio Therapeutics (NASDAQ:LOGC) and Dingdong (Cayman) (NYSE:DDL) are both small-cap retail/wholesale companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, earnings, institutional ownership, dividends, valuation, risk, community ranking and media sentiment. Is LOGC or DDL more profitable? Dingdong (Cayman) has a net margin of 0.90% compared to LogicBio Therapeutics' net margin of -141.03%. Dingdong (Cayman)'s return on equity of 40.86% beat LogicBio Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets LogicBio Therapeutics-141.03% -81.98% -52.13% Dingdong (Cayman) 0.90%40.86%2.88% Do analysts recommend LOGC or DDL? Dingdong (Cayman) has a consensus target price of $1.15, indicating a potential downside of 68.96%. Given Dingdong (Cayman)'s stronger consensus rating and higher probable upside, analysts plainly believe Dingdong (Cayman) is more favorable than LogicBio Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score LogicBio Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Dingdong (Cayman) 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Do insiders & institutionals have more ownership in LOGC or DDL? 46.1% of LogicBio Therapeutics shares are owned by institutional investors. Comparatively, 24.7% of Dingdong (Cayman) shares are owned by institutional investors. 8.1% of LogicBio Therapeutics shares are owned by insiders. Comparatively, 29.8% of Dingdong (Cayman) shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has more risk and volatility, LOGC or DDL? LogicBio Therapeutics has a beta of 2.06, meaning that its share price is 106% more volatile than the S&P 500. Comparatively, Dingdong (Cayman) has a beta of 0.45, meaning that its share price is 55% less volatile than the S&P 500. Does the MarketBeat Community favor LOGC or DDL? LogicBio Therapeutics received 79 more outperform votes than Dingdong (Cayman) when rated by MarketBeat users. Likewise, 64.08% of users gave LogicBio Therapeutics an outperform vote while only 44.44% of users gave Dingdong (Cayman) an outperform vote. CompanyUnderperformOutperformLogicBio TherapeuticsOutperform Votes9164.08% Underperform Votes5135.92% Dingdong (Cayman)Outperform Votes1244.44% Underperform Votes1555.56% Which has better valuation & earnings, LOGC or DDL? Dingdong (Cayman) has higher revenue and earnings than LogicBio Therapeutics. LogicBio Therapeutics is trading at a lower price-to-earnings ratio than Dingdong (Cayman), indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLogicBio Therapeutics$287M0.69-$317M-$5.79-1.30Dingdong (Cayman)$2.80B0.31-$14.07M$0.0941.17 Does the media prefer LOGC or DDL? In the previous week, Dingdong (Cayman) had 2 more articles in the media than LogicBio Therapeutics. MarketBeat recorded 2 mentions for Dingdong (Cayman) and 0 mentions for LogicBio Therapeutics. Dingdong (Cayman)'s average media sentiment score of 0.98 beat LogicBio Therapeutics' score of 0.00 indicating that Dingdong (Cayman) is being referred to more favorably in the news media. Company Overall Sentiment LogicBio Therapeutics Neutral Dingdong (Cayman) Positive SummaryDingdong (Cayman) beats LogicBio Therapeutics on 11 of the 16 factors compared between the two stocks. Get LogicBio Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for LOGC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LOGC vs. The Competition Export to ExcelMetricLogicBio TherapeuticsCatalog & mail IndustryRetail SectorNASDAQ ExchangeMarket Cap$203.97M$110.44B$26.27B$9.15BDividend YieldN/A3.62%172.58%3.85%P/E RatioN/A18.1025.3419.17Price / Sales0.690.883.7970.93Price / CashN/A26.1219.3734.83Price / Book0.845.615.944.62Net Income-$317M$3.04B$770.12M$246.06M LogicBio Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LOGCLogicBio Therapeutics0.7796 of 5 stars$7.54-2.8%N/AN/A$203.97M$287M0.0062DDLDingdong (Cayman)1.0701 of 5 stars$3.44+2.5%$1.15-66.5%+229.3%$811.45M$2.80B38.173,015News CoveragePositive NewsGap UpSFIXStitch Fix1.819 of 5 stars$5.24+6.5%$3.96-24.4%+52.6%$664.64M$1.34B-6.314,570HNSTHonest1.6 of 5 stars$6.09+3.7%$6.93+13.8%+71.9%$614.85M$344.36M-152.25190Analyst ForecastNews CoveragePositive NewsBWMXBetterware de México, S.A.P.I. de C.V.N/A$10.82-1.1%N/A-13.8%$403.62M$734.49M7.732,294Upcoming EarningsNews CoverageGap DownTDUPThredUp3.6777 of 5 stars$2.49+0.8%$3.50+40.6%+34.7%$283.26M$322.02M-3.892,377Insider TradeGap UpBZUNBaozun0.9084 of 5 stars$3.52+4.5%$3.20-9.1%+55.4%$216.69M$1.24B-6.527,827Gap UpAKAa.k.a. Brands2.067 of 5 stars$16.88-7.4%$24.00+42.2%+74.3%$179.55M$546.26M-5.841,300Analyst ForecastNews CoverageGap DownDIBS1stdibs.Com2.7275 of 5 stars$4.05flat$8.00+97.5%-12.9%$147.87M$84.68M-9.64310Upcoming EarningsAnalyst ForecastNews CoverageQRTEAQurate Retail2.0886 of 5 stars$0.36-1.4%N/A-70.6%$140.92M$10.92B-0.5020,300Analyst ForecastNews CoverageLVLULulu's Fashion Lounge3.5114 of 5 stars$0.86+0.8%$1.50+75.2%-59.2%$35.99M$355.17M-1.14740News CoverageGap Up Related Companies and Tools Related Companies Dingdong (Cayman) Alternatives Stitch Fix Alternatives Honest Alternatives Betterware de México, S.A.P.I. de C.V. Alternatives ThredUp Alternatives Baozun Alternatives a.k.a. Brands Alternatives 1stdibs.Com Alternatives Qurate Retail Alternatives Lulu's Fashion Lounge Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:LOGC) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersThe Real Hillbilly ElegyThe mountains of Appalachia are incredible to behold. Spanning thousands of miles across Alabama, Kentucky...Porter & Company | SponsoredThis quote from Elon says it all… (AI Breakthrough)MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredEx-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000”Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000. ...Colonial Metals | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredElon Social Security shock?“A Maniacal Sense of Urgency” We could be just days away from Elon Musk launching his next big venture. One...Altimetry | Sponsored2025 AI Blueprint features Nvidia’s march to $5 trillionNvidia is now one of the most valuable companies in the world. It currently ranks second, just behind Apple...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendThere's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a tra...Investors Alley | SponsoredHas Trump finally met his match?A new Chinese AI software called "DeepSeek" is sending shockwaves through the market. It's advanced enough ...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LogicBio Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LogicBio Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
